secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2026-04-17T23:59:59+00:00
Accession:  0001493152-26-017833
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte Biotechnology cancels 500,000 options, awards equal RSUs vesting immediately to CEO, CFO, and directors
--------------------------------------------------------------------------------

- CEO Geordan Pursglove: 350,000 options cancelled, 350,000 RSUs awarded; CFO Peter Stazzone: 50,000 each.
- Directors Holloway, Primus, Felix, Sawyer: each 25,000 options cancelled and RSUs awarded.
- RSUs granted under 2020 Stock Incentive Plan and vested immediately on April 15, 2026.
- Committee states swap provides better retention/incentive for officers and directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315226017833/0001493152-26-017833-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315226017833/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-017833

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer